News
Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback